Non-Resectable Cholangiocarcinoma

BACKGROUND Cholangiocarcinoma is a malignant neoplasia that originates in the bile ducts. Most patients with cholangiocarcinoma… Expand

AIM To perform a systematic review and meta-analysis on clinical outcomes of photodynamic therapy (PDT) in non-resectable… Expand

BACKGROUND/AIMS Standard treatments are not available for hilar nonresectable cholangiocarcinoma (NCC). It is unknown whether… Expand

SUMMARY Photodynamic therapy (PDT) is a cancer treatment modality that combines the use of a photosensitizing agent and a… Expand

The prognosis of patients with an unresectable bile duct cancer is poor. In 60-70% of patients, cholangiocarcinoma is located in… Expand

BACKGROUND Photodynamic therapy (PDT) has demonstrated promise in the palliative treatment of advanced cholangiocarcinoma. The… Expand

BACKGROUND & AIMS In nonrandomized trials, photodynamic therapy (PDT) had a promising effect on nonresectable cholangiocarcinoma… Expand

Symptoms occur late in cholangiocarcinoma and therefore only about half of the patients at the time of diagnosis are candidates… Expand

 

BACKGROUND AND AIMS Radiotherapy has been reported to be of benefit in prolonging the survival of patients with… Expand